ArticleCancer medicine2023

Cost-effectiveness analysis of tumor-infiltrating lymphocytes biomarkers guiding chemotherapy de-escalation in early triple-negative breast cancer.

Shiqi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.